Dual Functions of Treg in the Mucosal Barrier and Lung Cancer Microenvironment and Prospects for Targeted Therapy

Documenti analoghi

• Current Status of Treg Therapy in Transplantation and Autoimmune Disease
  di: Hongwen Li, et al.
  Pubblicazione: (2026)
• Upregulated TCF1+ Treg Cells With Stronger Function in Systemic Lupus Erythematosus Through Activation of the Wnt‐β‐Catenin
  di: Xingyue Zeng, et al.
  Pubblicazione: (2025)
• Effective Mucosal Adjuvantation of the Intranasal Enterovirus A71 Vaccine With Zymosan
  di: Chiao‐Li Chin, et al.
  Pubblicazione: (2025)
• Microplastics in Allergic Rhinitis: Multimechanistic Drivers of Barrier Disruption and Immune Dysregulation
  di: Xu Zhang, et al.
  Pubblicazione: (2025)
• Unravelling CD4+ T cell diversity and tissue adaptation of Tregs in abdominal aortic aneurysms through single‐cell sequencing
  di: Luna Zhai, et al.
  Pubblicazione: (2024)